Brief: Kintor Pharmaceutical Says Unit Entered Exclusive License Agreement With Gensun Biopharma
20/08/2020 16:34
Aug 20 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* UNIT ENTERED EXCLUSIVE LICENSE AGREEMENT WITH GENSUN
BIOPHARMA
INC.
* UNDER AGREEMENT GROUP OBTAINED FROM GENSUN EXCLUSIVE
LICENSE TO
DEVELOP & SELL PRODUCTS WITH GS19 PLB-1C
Source text for Eikon: ID:nHKS8nL1Vd
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint